IceCure Medical Ltd. (NASDAQ:ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing, today announced the commencement of a proposed public offering of its ordinary shares. All of the securities to be sold in the offering are to be offered by IceCure. The proposed public offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.
Fluor Reports Its Joint Venture With Petrosea Wins Contract To Install Grinding Mill At Grasberg Copper, Gold Mining District, No Terms Disclosed
Fluor to construct new mill as mine transitions from open pit to underground mine
IRVING, Texas--(BUSINESS WIRE)-- Fluor Corporation (NYSE:FLR) announced today that its joint venture with Petrosea – Fluor Petrosea
